Oligonucleotide & Precision Therapeutics (OPT Congress 2020)

  • 17-19 March 2020
  • Hyatt Regency Cambridge, MA, United States

Oligonucleotide & Precision Therapeutics (OPT Congress 2020) is a conference dedicated to the discovery, development and delivery of oligonucleotide and peptide therapeutics.

Oligonucleotide & Precision Therapeutics (OPT Congress 2020) covers topics such as:

  • Peptide discovery and delivery - next generation of targeted peptide therapeutics
  • Oligonucleotide discovery and delivery - aptamer, antisense and rna therapeutics
  • Drug discovery for rare diseases - genomic and proteomic targets and drug modalities

Oligonucleotide & Precision Therapeutics (OPT Congress 2020) brings together executives, directors, managers, and scientists from Biotechs, Pharma, Government and Healthcare and Academia working in:

  • Immunotherapy
  • Oligonucleotide Therapeutics
  • Gene Editing
  • Gene Therapy
  • Rare Diseases

Oligonucleotide & Precision Therapeutics (OPT Congress 2020) will be held in Cambridge, MA, United States on 17-19 March 2020.

Venue

Hyatt Regency Cambridge
575 Memorial Drive,
Cambridge,
Massachusetts,
United States
  View all Hotels near Venue
Booking.com
CHI - Cambridge Healthtech Institute
Rentalcars Savings

Past and Future Events

  • Oligonucleotide & Precision Therapeutics (OPT Congress) - Mar 2021, Cambridge, United States (71765)
  • Oligonucleotide & Precision Therapeutics (OPT Congress 2020) - 17-19 Mar 2020, Cambridge, United States (79263)
  • Oligonucleotide & Precision Therapeutics (OPT Congress 2019) - 26-28 Mar 2019, Cambridge, United States (71766)

Important

Please, check the official conference website for possible changes, before you make any traveling arrangements

Prices are for evaluation only.